Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danoprevir Boosted with Ritonavir in Treatment-Naive Chronic Hepatitis C
NCT01220947Phase 2Completed
- Sponsor
- Roche
- Start
- Nov 2010
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands
- Countries
- 11
01
Overview
A Phase 2 trial of danoprevir in hepatitis C (HCV), sponsored by Roche. Started Nov 2010; status: completed.
02
Drugs
danoprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01220947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01220947.